General Information of Drug (ID: DMPLZ7E)

Drug Name
HC-Toxin Drug Info
Synonyms
HC Toxin; Cyclo(aoe-pro-ala-ala); Cyclo(2-amino-8-oxo-9,10-epoxydecanoic acid-prolyl-alanyl-alanine); Cyclic(L-alanyl-D-alanyl-eta-oxo-L-alpha-aminooxiraneoctanoyl-D-prolyl); Cyclo(L-alanyl-D-alanyl-(alphaS,2S)-alpha-amino-eta-oxooxiraneoctanoyl-D-prolyl); (3S,6R,9S,12R)-6,9-dimethyl-3-[6-(oxiran-2-yl)-6-oxohexyl]-1,4,7,10-tetrazabicyclo[10.3.0]pentadecane-2,5,8,11-tetrone
Therapeutic ClassAnticancer Agents
Cross-matching ID
PubChem CID
107864
ChEBI ID
CHEMBL48028
TTD Drug ID
D06RQU

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Synaptic vesicle cycle 2.11 0.00e+0 63/78 (80.77%) STXBP1;SLC1A1;ATP6V1D;...
Citrate cycle (TCA cycle) 2.06 4.91e-3 30/30 (100%) IDH3A;MDH1;DLD;...
Steroid biosynthesis 2.02 3.27e-3 19/20 (95%) LIPA;MSMO1;DHCR7;...
Fructose and mannose metabolism 2.01 2.45e-3 30/33 (90.91%) ALDOC;AKR1B1;ALDOA;...
Valine, leucine and isoleucine degradation 1.82 2.55e-2 42/48 (87.5%) HMGCS1;HIBCH;DLD;...
Propanoate metabolism 1.80 3.11e-2 30/34 (88.24%) HIBCH;DLD;MMUT;...
Oxidative phosphorylation 1.79 2.80e-2 93/133 (69.92%) ATP6V1D;NDUFB3;NDUFB6;...
Collecting duct acid secretion 1.74 3.19e-2 22/27 (81.48%) ATP6V1D;ATP6V0D1;ATP6V1E1;...
Pentose phosphate pathway 1.71 3.16e-2 25/30 (83.33%) ALDOC;TKTL1;ALDOA;...
Terpenoid backbone biosynthesis 1.71 3.14e-2 18/22 (81.82%) IDI1;HMGCS1;DHDDS;...
Mineral absorption 1.71 2.94e-2 48/60 (80%) MT1X;MT1E;MT2A;...
Prion disease 1.70 2.86e-2 209/273 (76.56%) HSPA1A;SLC25A4;TUBB2A;...
Lysosome 1.65 4.76e-2 115/128 (89.84%) PLA2G15;NPC1;LGMN;...
Aldosterone synthesis and secretion 1.64 4.97e-2 85/98 (86.73%) STAR;ADCY9;AGT;...
Diabetic cardiomyopathy 1.63 4.66e-2 162/203 (79.8%) SLC25A4;MPC1;PIK3CD;...
Carbohydrate digestion and absorption 1.61 4.91e-2 37/47 (78.72%) PIK3CD;ATP1B2;HK1;...
Transcriptional misregulation in cancer -1.72 4.67e-2 158/192 (82.29%) PROM1;SUPT3H;SS18;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.37uM - 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
1HAEo- CVCL_0128 Homo sapiens 10uM 24H
NL20 CVCL_0461 Homo sapiens 10uM 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H
Normal (Fibroblast)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HFL1 CVCL_4295 Homo sapiens 10uM 24H
IMR-90 CVCL_0347 Homo sapiens 10uM 24H
WI-38 CVCL_0579 Homo sapiens 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H